US FDA opens first overseas office
This article was originally published in SRA
The US Food and Drug Administration has opened its first overseas office, in Beijing, China. The move is part of an effort to better ensure the safety of food, drugs and medical devices being exported into the US. Two more FDA offices will be opened in China, in Guangzhou and Shanghai1, with offices also planned in India, Europe, Latin America and the Middle East2.
You may also be interested in...
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.